scorecardresearchGlenmark Life Sciences Share Price Live NSE, BSE, Today - Glenmark Life

Glenmark Life Sciences

BSE: 543322 | NSE: GLS | ISIN: INE03Q201024 | SECTOR: Biotechnology & Drugs

832.65 -6.60 (-0.79%)

21 Jun 2024, 09:58 (IST)
  • Open

    857.00
  • High

    857.00
  • Low

    826.00
  • Prev Close

    839.25
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    102.02B
  • Volume

    2.74K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    -

Promoter Pledge Holding - 7.84%

Promoter NameNo of SharesPercentage
GLENMARK PHARMACEUTICALS LIMITED96,09,5717.84%

Company Description

  • Biotechnology & Drugs
  • BSE

    543322
  • NSE

    GLS
  • ISIN

    INE03Q201024

Glenmark Life Sciences Limited is an India-based developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas. The Company is providing contract development and manufacturing (CDMO) services to a range of multinational and specialty pharmaceutical companies. Its primary therapy areas include cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, oncology, pain management (anti-migraine, analgesic) and anti-infectives (antibiotic). It also develops APIs in the therapeutic areas such as anti-fungal, anti-histaminic, anti-acne, anti-emetic, ophthalmologic agent, urinary and anti-spasmodic. It has a diversified portfolio of around 151 molecules & supplies its products to customers in India, Europe, North America, Latin America, Japan and the rest of the world. Its four manufacturing facilities are located in Ankleshwar, Dahej, Mohol and Kurkumbh with a total installed capacity of approximately 1198 KL.

Company Officers

  • Yasir Rawjee

    Chief Executive Officer, Managing Director, Executive Director
  • Tushar Mistry

    Chief Financial Officer, Senior Vice President
  • Rudalf Corriea

    Company Secretary, Compliance Officer
  • Vinod Naik

    Group Vice President, Head of Technical Operations, Whole Time Director
  • Mathew George

    Vice President, Head of Regulatory Affairs
  • Palle Acharyulu

    Group Vice President - Research & Development
  • Navin Agrawal

    Head - Corporate Quality, API
  • Sumantra Mitra

    Head - Human Resources